The re-emergence of tuberculosis
- PMID: 8054087
- DOI: 10.1146/annurev.pu.15.050194.001511
The re-emergence of tuberculosis
Abstract
PIP: Tuberculosis (TB) is reemerging as a major public health problem worldwide. The emergence of multidrug resistance and the interaction between TB and HIV infection are responsible for this surge. Immunologists, epidemiologists, economists, clinicians, policymakers, and heads of TB control programs attended a 1993 public health conference called Tuberculosis--Back to the Future, at the London School of Hygiene and Tropical Medicine. They agreed that urgent research is needed on diagnostics, new drugs, vaccines, and control strategies to address the reemergence of TB. They also called for a much higher investment in existing cost effective methods for TB control. Research scientists and staff of national TB control programs must work closely together to assure success of any strategy. Before the HIV epidemic, the risk of TB infection in developing countries fell 1-5% per year. The HIV epidemic has reversed this trend. It also fell in developed countries. In the US, the risk began to increase in 1986 in New York City due to increased immigration from TB endemic countries, interaction between TB and HIV, and decay in the health infrastructure supporting TB control programs. Treatment failures or relapses due to disorganized treatment programs account for most multidrug resistance in the US as well as in other countries. Research areas of diagnostics improvement include clinical evaluation, microscopy, culture, and radiographic examination. Drug research areas are in new drugs to improve patient compliance; investigation of the mechanism of virulence of Mycobacterium tuberculosis to understand mycobacterial persistence, thus helping in the development of new drugs; and operations research of rational use of drugs by clinicians. Vaccine research is perhaps the most important research, especially since the current vaccine is not always effective. TB control program and operational issues include case finding and treatment, chemoprophylaxis, treatment regimens, operational research, supervision, and drug supply.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.Tuberculosis (Edinb). 2010 May;90(3):182-7. doi: 10.1016/j.tube.2010.03.008. Epub 2010 Apr 10. Tuberculosis (Edinb). 2010. PMID: 20382566 Review.
-
HIV infection and multidrug-resistant tuberculosis: the perfect storm.J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665. J Infect Dis. 2007. PMID: 17624830 Review.
-
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.Bull World Health Organ. 2002;80(6):489-95; discussion 495-500. Bull World Health Organ. 2002. PMID: 12132008 Free PMC article.
-
Therapeutic review: tuberculosis.Cent Afr J Med. 1991 Aug;37(8):250-9. Cent Afr J Med. 1991. PMID: 1807799 Review.
Cited by
-
Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.BMC Med Ethics. 2004 Mar 12;5:E2. doi: 10.1186/1472-6939-5-2. BMC Med Ethics. 2004. PMID: 15113419 Free PMC article.
-
The history of ultraviolet germicidal irradiation for air disinfection.Public Health Rep. 2010 Jan-Feb;125(1):15-27. doi: 10.1177/003335491012500105. Public Health Rep. 2010. PMID: 20402193 Free PMC article.
-
Tuberculosis in migrant populations. A systematic review of the qualitative literature.PLoS One. 2013 Dec 5;8(12):e82440. doi: 10.1371/journal.pone.0082440. eCollection 2013. PLoS One. 2013. PMID: 24349284 Free PMC article. Review.
-
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis.Microorganisms. 2023 Sep 10;11(9):2277. doi: 10.3390/microorganisms11092277. Microorganisms. 2023. PMID: 37764122 Free PMC article. Review.
-
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077. Clin Pract. 2021. PMID: 34563006 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical